Status: current, Defined. Date: 30-Jun 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4731051000168116 | Rubifen LA (methylphenidate hydrochloride 20 mg) modified release capsule, 30 capsules, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4731061000168119 | Rubifen LA 20 mg modified release capsule, 30, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Rubifen LA 20 mg modified release capsule, 30, blister pack | Is a | Rubifen LA 20 mg modified release capsule, 30 | true | Inferred relationship | Some | ||
| Rubifen LA 20 mg modified release capsule, 30, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Rubifen LA 20 mg modified release capsule, 30, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Rubifen LA 20 mg modified release capsule, 30, blister pack | has TP | Rubifen LA | true | Inferred relationship | Some | ||
| Rubifen LA 20 mg modified release capsule, 30, blister pack | has TPUU | Rubifen LA 20 mg modified release capsule | true | Inferred relationship | Some | 1346615777 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Schedule 8 medications reference set
Containered trade product pack reference set
FHIR